pulmonary hyaline membrane

The Clinical and Pathological Study of Perinatal Pulmonary Hyaline Membrane Disease in 44 Cases

44例围产儿肺透明膜病的临床和病理研究

The effect of pulmonary surfactant in company with nasal continuous positive airway pressure treatment on pulmonary hyaline membrane disease

肺表面活性物质与鼻塞持续气道正压通气联合治疗肺透明膜病疗效观察

Conclusion CDFM is an important method in diagnosing PDA, evaluating pulmonary hypertension and differentiating persistent fetal circulation. Chest film is helpful to determing degree of cardiac pulmonary edema and differentiating hyaline membrane diseases, pneumonia.

结论CDFM是诊断PDA和估测肺动脉高压、鉴别持续胎儿循环的重要方法，胸片有助于判断心源性肺水肿程度和鉴别肺透明膜病、肺炎。

Neonatal pulmonary hyaline membrane disease is a serious disease in the early newborn.

新生儿肺透明膜病是新生儿早期的严重疾病。

Use of Ambroxol in prevention of pulmonary hyaline membrane disease of premature infants

沐舒坦预防早产儿肺透明膜病

Clinical Study on Curing Hyaline Membrane Disease with Pulmonary Surfactant

肺表面活性物质替代治疗新生儿肺透明膜病临床研究

Blood capillary of alveolar wall engorgement and pulmonary hyaline membrane are formed, and the infiltration of inflammatory cells in alveolar spaces. In the treatment group, these changes were less obvious, and the amplitude decreased.

肺泡壁毛细血管充血扩张，有肺透明膜形成。肺间质、肺泡腔内有大量炎性细胞浸润，治疗组以上损伤程度明显减轻。